Chronic Hives - CPL | US

Offer Details:

Offer Name: Chronic Hives - CPL | US
Payout: $13.00 / CPA
Preview: Preview Landing Page
Categories: Clinical Trials
Network: DYNU IN MEDIA
Last Updated: Aug 29, 2025
Countries: US
Run Offer
Chronic Hives - CPL | US
NEED PROOF

Ages: 18+
Gender: Any

Study Description:
This study is testing an investigational injectable medication for the treatment of chronic spontaneous urticaria (CSU), also known as hives. Participants will receive either the investigational medication or a placebo for approximately 6 months. Following 6 months of the treatment period, participants receiving the placebo will enter an active treatment phase where they will receive the investigational medication. Additional procedures include vital signs, laboratory assessments, questionnaires, and e-diary completion. Total participation will last approximately 1 year and 5 months with up to19 clinic visits throughout the study. Eligibility for the study will be determined by the study doctor following one in-person screening visit to the clinic. Trial-related procedures and study medication will be provided at no cost. 


Questions/Answers to Screener:
Have you been diagnosed with CSU (hives) for at least 6 months?
[PATIENT NOTE]
Chronic spontaneous urticaria (CSU) is a condition that is characterized by itchy hives, deep tissue swelling (angioedema), or both for more than 6 weeks. This type of chronic urticaria has no specific cause or trigger.
(ANSWER: YES)

Have you experienced any of the following recurring symptoms of CSU for 6 weeks or longer, despite taking allergy medication (H1 antihistamines)?
- Superficial red or pale skin swelling known as wheals
- Painful swelling affecting the lips, eyelids, face, hands, feet, or genitals known as angioedema
- Intense itching
(ANSWER: YES)

In the last month, have you taken or are you currently taking a stable dose of any of the following medication to treat your CSU?
- Zyrtec (Cetirizine)
- Xyzal (Levocetirizine)
- Claritin (Loratadine)
- Clarinex (Desloratadine)
- Allegra (Fexofenadine)
(ANSWER: YES)

Do you currently have asthma that requires treatment with dual ICS-LABA therapy?
Examples of dual ICS-LABA therapy include, but are not limited to:
- Advair
- Symbicort
- Dulera
- Azmacort
- Breo Ellipta
- Fostair
(ANSWER: NO)

Would you be willing to complete an electronic diary during screening and throughout the duration of the study?
(ANSWER: YES)

Mailer Access Key
https://www.affiliateaccesskey.com/m-dzkm-u47-8ea2d11d97c2e4419f1196b13a5883ca
Optout Link
https://www.twonailhall.com/o-dzkm-u47-8dfe40bd444cf5cfba313bee015c1b0e

DYNU IN MEDIA


DYNU IN MEDIA is a super match CPA/CPL network for earning money online that provides you with all techniques allowing you to monetize your traffic in all channels. We guarantee outstanding support to our publishers. Our devoted team with experience in the affiliate marketing industry will give you full-assist, direct offers in a wide-ranging variety of verticals and top GEOs, and a flexible payment schedule of NET15 & NET30. Hitting more than 20,000 leads generated daily for over 200 influential clients, along with an increasing number of HQ publishers to 300 and more, DYNU IN MEDIA is taking high pride in our professionalism and high integrity.